Novel human beta2 integrin alpha subunit

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) A61P 25/00 (2006.01) A61P 37/00 (2006.01) C07K 14/705 (2006.01) C07K 16/28 (2006.01)

Patent

CA 2425818

The invention provides methods for reducing inflammation at the site of a central nervous system injury comprising the step of administering to an individual an effective amount of a small molecule that inhibits alpha-d binding. In particular, the methods of the invention comprising a central nervous system injury which is a spinal cord injury. Methods to treat spinal cord injury using alpha-d monoclonal antibodies are disclosed.

L'invention concerne des méthodes de traitement de traumatismes médullaires au moyen d'anticorps monoclonaux anti alpha >d<.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Novel human beta2 integrin alpha subunit does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel human beta2 integrin alpha subunit, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel human beta2 integrin alpha subunit will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1824074

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.